Tivic health funded study begins enrollment for novel non-invasive bioelectronic approach to vagus nerve stimulation

San francisco--(business wire)--tivic health® systems, inc. (“tivic”, nasdaq: tivc), a health tech company that develops and commercializes bioelectronic medicine, announced today that the research study that the company is funding at the feinstein institutes for medical research has received study approval from the institutional review board (“irb”) and has initiated study recruitment and enrollment for its novel non-invasive bioelectronic device approach to vagus nerve stimulation. an irb is.
TIVC Ratings Summary
TIVC Quant Ranking